Delivery Order SPE2DB25D3402-SPE2DB25FUGJQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injectors. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injector devices. This firm fixed price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors, with an ultimate completion date of September 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for Skyrizi 360 mg/2.4 ml on-body injectable medication. The contract, which is not set-aside and operates under firm fixed-price terms, was awarded on July 25, 2025, with a completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger vehicle,...
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injectors. This firm fixed-price, non-competitive delivery order is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,797.51 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen injectors. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830.00 under a firm fixed price contract. The order, which is expected to be completed by September 9, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body applicator units. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of September 11, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was awarded on July 18, 2025. This award represents a non-set-aside, competitively awarded contract and constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB25FUGJQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injectable medication. This firm fixed-price delivery order, issued on July 29, 2025, will be completed by August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The parent IDC serves as a flexible contracting vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 7/29/25 |